Showing results (471-480 of 864) with videos related to
Sort By:
Pageof 87
Current Drug Discovery Technologies|January 29, 2019
Antimicrobial Activity of Agarwood Oil Against Multiple-Drug-Resistant (MDR) Microbes of Clinical, Food and Environmental OriginBhoj R Singh, Dharmendra K Sinha, Vinodh K Or, et al.Current Drug Discovery Technologies|February 5, 2019
In Vitro Protective Effect of Ascorbic Acid Against Antibiotic-Induced HepatotoxicityVeneta Simon, Sreerag K V, R Sasikumar, et al.Current Drug Discovery Technologies|July 15, 2017
Designing of Selective γ-Secretase Inhibitory Benzenesulfonamides through Comparative In Vitro and In Silico AnalysisNeeraj Masand, Satya P Gupta, Ratan Lal KhosaCurrent Drug Discovery Technologies|July 15, 2017
A New Potent NS5A Inhibitor in the Management of Hepatitis C Virus: RavidasvirEnas Hafez, Tamer Elbaz, Mohamed El Kassas, et al.Current Drug Discovery Technologies|February 23, 2018
Molecular Docking in Formulation and DevelopmentTejinder Kaur, Ashwini Madgulkar, Mangesh Bhalekar, et al.Current Drug Discovery Technologies|February 23, 2018
Potentials of PKC in Cancer Progression and Anticancer Drug DevelopmentSuman J Deka, Vishal TrivediCurrent Drug Discovery Technologies|November 3, 2018
In silico Analysis and Molecular Docking Studies of Novel 4-Amino-3- (Isoquinolin-4-yl)-1H-Pyrazolo[3,4-d]Pyrimidine Derivatives as Dual PI3-K/mTOR InhibitorsIshan I Panchal, Sandip N Badeliya, Rakesh Patel, et al.Current Drug Discovery Technologies|November 13, 2018
Efficacy of β-D-Mannuronic Acid [M2000] on the Pro-Apoptotic Process and Inflammatory-Related Molecules NFκB, IL-8 and Cd49d using Healthy Donor PBMCAtousa Khalatbari, Mehdi Mahdavi, Fahimeh Jafarnezhad, et al.Current Drug Discovery Technologies|November 7, 2018
Design, Synthesis and Pharmacological Evalution of 1,3,4-Oxadiazole Derivatives as Collapsin Response Mediator Protein 1 (CRMP 1) InhibitorsIshan I Panchal, Roshani Rajput, Ashish D PatelCurrent Drug Discovery Technologies|December 17, 2016
In Silico Design of New Inhibitors of Guanine Phosphoribosyltransferase (GPRT) from Giardia lamblia as Antiparasitic Drug CandidatesGustavo M das Neves, Luciano P Kagami, Ricardo P Rodrigues, et al.Pageof 87